BAFF/BLyS/TNFSF13B Antibody (137314) [Phycoerythrin]

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

BAFF, also known as TALL-1, BLyS, and THANK, is a type II transmembrane glycoprotein belonging to the TNF superfamily and has been designated as TNF superfamily member 13B (TNFSF13B). Human BAFF is a 285 amino acid (aa) protein consisting of a 218 aa extracellular domain, a 21 aa transmembrane region and a 46 aa cytoplasmic tail (1, 2). BAFF has the typical structural characteristics of the TNF superfamily ligands. It is a homotrimeric protein having the structurally conserved motif known as TNF homology domain (3, 4). A higher ordered structure composed of a cluster of trimeric units resembling the structure of a viral capsid has also been reported (4). Human BAFF may be shed from the cell surface by proteolytic cleavage between Arg133 and Ala134 to yield a soluble form of the protein that is detectable in serum (1, 5). Within the TNF superfamily BAFF shares the highest homology (48%) with APRIL (1). BAFF shares with APRIL the ability to bind to BCMA and TACI and also binds specifically to BAFF Receptor (BAFF R, also known as BR3 or TNFSFR13C), which is the principal BAFF receptor (6 - 8). All three receptors are type III transmembrane proteins that are expressed in B cells. BAFF and APRIL can form active heteromers that bind to TACI (9). BAFF is expressed in peripheral blood mononuclear cells, spleen and lymph nodes. Its expression in resting monocytes is up-regulated by IFN-alpha , IFN-beta , LPS and IL-10. BAFF provides critical survival signals to a subset of B cells with intermediate maturation status (T2 B cells) during the immune response (10). BAFF also plays an important role in the development of lymphoid tissue and enhances the survival of activated memory B cells (7, 11). Human and mouse BAFF share 86% aa sequence identity (1).

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 2 applications: Flow Cytometry, ICC.

Showing Publications 1 - 2 of 2.

Publications using IC1241P	Applications	Species
Ohmatsu H, Sugaya M, Miyagaki T, Suga H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S BAFF levels are increased in lesional skin and sera in patients with cutaneous T-cell lymphoma. Br. J. Dermatol., 2012-07-05;167(2):359-67. 2012-07-05 [PMID: 22512719] (Flow Cytometry, Human)	Flow Cytometry	Human
Nishio M, Endo T, Tsukada N, Ohata J, Kitada S, Reed JC, Zvaifler NJ, Kipps TJ Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood, 2005-04-28;106(3):1012-20. 2005-04-28 [PMID: 15860672] (Flow Cytometry, ICC, Human)	Flow Cytometry, ICC	Human

Array IC1241P

• BAFF/BLyS/TNFSF13B Antibodies
• BAFF/BLyS/TNFSF13B Antibody Pair
• BAFF/BLyS/TNFSF13B ELISA Kit
• BAFF/BLyS/TNFSF13B Lysate
• BAFF/BLyS/TNFSF13B Proteins
• BAFF/BLyS/TNFSF13B Proteins and Enzymes
• BAFF/BLyS/TNFSF13B ELISAs